ArticleGastroenterology report2026

Celecoxib suppresses colorectal cancer growth by inhibiting propionyl-CoA carboxylase alpha chain-mediated epithelial-mesenchymal transition and angiogenesis.

Chuyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.